{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T03:02:31Z","timestamp":1776308551198,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2000,8,1]],"date-time":"2000-08-01T00:00:00Z","timestamp":965088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2000,8]]},"DOI":"10.1016\/s0028-3908(99)00242-7","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T22:46:48Z","timestamp":1027637208000},"page":"1567-1574","source":"Crossref","is-referenced-by-count":122,"title":["Anticonvulsant activity of two metabotropic glutamate Group I antagonists selective for the mGlu5 receptor: 2-methyl-6-(phenylethynyl)-pyridine (MPEP), and (E)-6-methyl-2-styryl-pyridine (SIB 1893)"],"prefix":"10.1016","volume":"39","author":[{"given":"Astrid G","family":"Chapman","sequence":"first","affiliation":[]},{"given":"Karl","family":"Nanan","sequence":"additional","affiliation":[]},{"given":"Martin","family":"Williams","sequence":"additional","affiliation":[]},{"given":"Brian S","family":"Meldrum","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0028-3908(99)00242-7_BIB1","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1046\/j.1471-4159.1997.69010151.x","article-title":"Metabotropic glutamate receptor mGluR5 in astrocytes: pharmacological properties and agonist regulation","volume":"69","author":"Bal\u00e1zs","year":"1997","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/S0028-3908(99)00242-7_BIB2","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0028-3908(98)00159-2","article-title":"Neuroprotective activity of the potent and selective mGlu1a metabotropic glutamate receptor antagonist, (+)-2-methyl-4-carboxyphenylglycine (LY 367385): comparison with LY367366, a broader spectrum antagonist with equal affinity for mGlu1a and mGlu5 receptors","volume":"38","author":"Bruno","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/S0028-3908(99)00242-7_BIB3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0014-2999(99)00014-X","article-title":"Anticonvulsant actions of LY 367385 (+)-2-methyl-4-carboxyphenylglycine) and AIDA (RS)-1-aminoindan-1,5-dicarboxylic acid","volume":"368","author":"Chapman","year":"1999","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/S0028-3908(99)00242-7_BIB4","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1146\/annurev.pharmtox.37.1.205","article-title":"Pharmacology and functions of metabotropic glutamate receptors","volume":"37","author":"Conn","year":"1997","journal-title":"Annual Review of Pharmacology and Toxicology"},{"key":"10.1016\/S0028-3908(99)00242-7_BIB5","first-page":"516","article-title":"Modulation of seizure activity in mice by metabotropic glutamate receptor ligands","volume":"276","author":"Dalby","year":"1996","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/S0028-3908(99)00242-7_BIB6","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0028-3908(97)00001-4","article-title":"(RS)-2-Chloro-5-hydroxyphenylglycine (CHPG) activates mGlu5, but not mGlu1, receptors expressed in CHO cells and potentiates NMDA responses in the hippocampus","volume":"36","author":"Doherty","year":"1997","journal-title":"Neuropharmacology"},{"key":"10.1016\/S0028-3908(99)00242-7_BIB7","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0304-3940(96)12301-6","article-title":"Activation of group I mGluRs potentiates NMDA responses in rat hippocampal slices","volume":"203","author":"Fitzjohn","year":"1996","journal-title":"Neuroscience Letters"},{"key":"10.1016\/S0028-3908(99)00242-7_BIB8","first-page":"249P","article-title":"2-Methyl-6-(phenylethynyl)-pyridine (MPEP): a novel potent,subtype-selective and systemiucally active antagonist at metabotropic glutamate receptor subtype 5","volume":"126","author":"Gasparini","year":"1999","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/S0028-3908(99)00242-7_BIB9","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1126\/science.1321503","article-title":"The role of GABAB receptor activation in absence seizures of lethargic (ch\/ch) mice","volume":"257","author":"Hosford","year":"1992","journal-title":"Science"},{"key":"10.1016\/S0028-3908(99)00242-7_BIB10","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1528-1157.1997.tb01729.x","article-title":"Utility of the lethargic (lh\/lh) mouse model of absence seizures in predicting the effects of lamotrigine, vigabatrin, tiagabine, gabapentin, and topiramate against human absence seizures","volume":"38","author":"Hosford","year":"1997","journal-title":"Epilepsia"},{"key":"10.1016\/S0028-3908(99)00242-7_BIB11","doi-asserted-by":"crossref","first-page":"3970","DOI":"10.1523\/JNEUROSCI.15-05-03970.1995","article-title":"Molecular, functional, and pharmacological characterization of the metabotropic glutamate receptor type 5 splice variants: comparison with mGluR1","volume":"15","author":"Joly","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/S0028-3908(99)00242-7_BIB12","first-page":"99","article-title":"A simplified method of evaluating dose effect experiments","volume":"96","author":"Litchfield","year":"1949","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/S0028-3908(99)00242-7_BIB13","doi-asserted-by":"crossref","first-page":"5196","DOI":"10.1523\/JNEUROSCI.17-13-05196.1997","article-title":"Mice lacking metabotropic glutamate receptor 5 show impaired learning and reduced CA1 long-term potentiation (LTP) but normal CA3 LTP","volume":"17","author":"Lu","year":"1997","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/S0028-3908(99)00242-7_BIB14","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0028-3908(99)00021-0","article-title":"Biochemical and electrophysiological studies on (S)-(+)-2-(3\u2032-carboxybicyclo[1.1.1]pentyl)-glycine (CBPG), a novel mGlu5 receptor agonist endowed with mGlu1 receptor antagonist activity","volume":"38","author":"Mannaioni","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/S0028-3908(99)00242-7_BIB15","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1046\/j.1471-4159.1997.69041467.x","article-title":"The metabotropic glutamate receptor mGluR5 induces calcium oscillations in cultured astrocytes via protein kinase C phosphorylation","volume":"69","author":"Nakahara","year":"1997","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/S0028-3908(99)00242-7_BIB16","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1021\/jm00019a002","article-title":"1-Aminoindan-1,5-dicarboxylic acid: a novel antagonist at phospholipase C-linked metabotropic glutamate receptors","volume":"38","author":"Pellicciari","year":"1995","journal-title":"Journal of Medical Chemistry"},{"key":"10.1016\/S0028-3908(99)00242-7_BIB17","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1021\/jm960254o","article-title":"(S)-(+)-2-(3\u2032-carboxycyclo[1.1.1]pentyl)-glycine, a structurally new group 1 metabotropic glutamate receptor antagonist","volume":"39","author":"Pellicciari","year":"1996","journal-title":"Journal of Medical Chemistry"},{"key":"10.1016\/S0028-3908(99)00242-7_BIB18","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/sj.bjp.0700999","article-title":"Enhancement of NMDA responses by Group I metabotropic receptor activation in striatal neurones","volume":"120","author":"Pisani","year":"1997","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/S0028-3908(99)00242-7_BIB19","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/sj.bjp.0702677","article-title":"Antagonism of the mGlu5 agonist 2-chloro-5-ydroxyphenylglycine by the novel selective mGlu5 antagonisty 6-methyl-2-(phenylethynyl)-pyridine (MPEP) in the thalamus","volume":"127","author":"Salt","year":"1999","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/S0028-3908(99)00242-7_BIB20","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1046\/j.1471-4159.1994.63020769.x","article-title":"3,5-Dihydroxyphenylglycine is a highly selective agonist for phosphoinositide-linked metabotropic glutamate receptors in the rat hippocampus","volume":"63","author":"Schoepp","year":"1994","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/S0028-3908(99)00242-7_BIB21","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0014-2999(97)89649-5","article-title":"Prolonged anticonvulsant action of glutamate metabotropic receptor agonists in inferior colliculus of genetically epilepsy-prone rats","volume":"327","author":"Tang","year":"1997","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/S0028-3908(99)00242-7_BIB22","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1046\/j.1471-4159.1994.62062492.x","article-title":"(S)-4-carboxy-3-hydroxyphenylglycine, an antagonist of metabotropic glutamate receptor (mGluR)1a and an agonist of mGluR2, protects against audiogenic seizures in DBA\/2 mice","volume":"62","author":"Thomsen","year":"1994","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/S0028-3908(99)00242-7_BIB23","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/0028-3908(95)00083-I","article-title":"Induction or protection of limbic seizures in mice by mGluR subtype selective agonists","volume":"34","author":"Tizzano","year":"1995","journal-title":"Neuropharmacology"},{"key":"10.1016\/S0028-3908(99)00242-7_BIB24","first-page":"170","article-title":"SIB-1757 and SIB-1893: selective, non-competitive antagonists of metabotropic glutamate receptor type 5","volume":"290","author":"Varney","year":"1999","journal-title":"Journal of Pharmacology and Experimental Therapeutics"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390899002427?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390899002427?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,2,4]],"date-time":"2020-02-04T23:59:36Z","timestamp":1580860776000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390899002427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,8]]},"references-count":24,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2000,8]]}},"alternative-id":["S0028390899002427"],"URL":"https:\/\/doi.org\/10.1016\/s0028-3908(99)00242-7","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2000,8]]}}}